Abbott Laboratories stock at EUR 92.61 ahead of Xetra open: devices slightly higher
Published on 10/26/2026 at 08:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness and market context
- Abbott Laboratories develops and markets pharmaceutical and medical products across several healthcare businesses.
- The home-market benchmark is the S&P 500 in the United States.
- Abbott Laboratories stock trades pre-market at EUR 92.61 at 8:10 a.m. CET at Lang & Schwarz on October 26, 2026, 0.79 percent above the Xetra close of October 23, 2026.
Abbott Laboratories develops, manufactures and markets pharmaceutical and medical products, with business lines in vascular devices, diagnostic systems, nutrition products and medicines, according to the MarketScreener company profile. Abbott Laboratories stock trades pre-market at EUR 92.61 at 8:10 a.m. CET at Lang & Schwarz on October 26, 2026, 0.79 percent above the Xetra close of October 23, 2026 (EUR 91.88).
Ahead of the Xetra open
The difference equals plus EUR 0.73 versus the Xetra close. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Abbott Laboratories stock.
Abbott's business lines
Its portfolio spans diagnostics, medical devices, nutritionals and branded generic medicines, serving healthcare markets globally, according to the MarketScreener profile. Market context: Market report S&P 500.
